402 related articles for article (PubMed ID: 20860838)
1. P190B RhoGAP has pro-tumorigenic functions during MMTV-Neu mammary tumorigenesis and metastasis.
McHenry PR; Sears JC; Herrick MP; Chang P; Heckman-Stoddard BM; Rybarczyk M; Chodosh LA; Gunther EJ; Hilsenbeck SG; Rosen JM; Vargo-Gogola T
Breast Cancer Res; 2010; 12(5):R73. PubMed ID: 20860838
[TBL] [Abstract][Full Text] [Related]
2. Haploinsufficiency for p190B RhoGAP inhibits MMTV-Neu tumor progression.
Heckman-Stoddard BM; Vargo-Gogola T; McHenry PR; Jiang V; Herrick MP; Hilsenbeck SG; Settleman J; Rosen JM
Breast Cancer Res; 2009; 11(4):R61. PubMed ID: 19703301
[TBL] [Abstract][Full Text] [Related]
3. Cdc42 overexpression induces hyperbranching in the developing mammary gland by enhancing cell migration.
Bray K; Gillette M; Young J; Loughran E; Hwang M; Sears JC; Vargo-Gogola T
Breast Cancer Res; 2013; 15(5):R91. PubMed ID: 24074261
[TBL] [Abstract][Full Text] [Related]
4. Tiam1-deficiency impairs mammary tumor formation in MMTV-c-neu but not in MMTV-c-myc mice.
Strumane K; Rygiel T; van der Valk M; Collard JG
J Cancer Res Clin Oncol; 2009 Jan; 135(1):69-80. PubMed ID: 18592271
[TBL] [Abstract][Full Text] [Related]
5. P190B RhoGAP overexpression in the developing mammary epithelium induces TGFβ-dependent fibroblast activation.
Gillette M; Bray K; Blumenthaler A; Vargo-Gogola T
PLoS One; 2013; 8(5):e65105. PubMed ID: 23717689
[TBL] [Abstract][Full Text] [Related]
6. The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling.
Brantley-Sieders DM; Zhuang G; Hicks D; Fang WB; Hwang Y; Cates JM; Coffman K; Jackson D; Bruckheimer E; Muraoka-Cook RS; Chen J
J Clin Invest; 2008 Jan; 118(1):64-78. PubMed ID: 18079969
[TBL] [Abstract][Full Text] [Related]
7. Coordination of Rho and Rac GTPase function via p190B RhoGAP.
Bustos RI; Forget MA; Settleman JE; Hansen SH
Curr Biol; 2008 Oct; 18(20):1606-11. PubMed ID: 18948007
[TBL] [Abstract][Full Text] [Related]
8. Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumors.
Landis MD; Seachrist DD; Abdul-Karim FW; Keri RA
Oncogene; 2006 Jun; 25(23):3325-34. PubMed ID: 16434967
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice.
Zinser GM; Welsh J
Carcinogenesis; 2004 Dec; 25(12):2361-72. PubMed ID: 15333467
[TBL] [Abstract][Full Text] [Related]
10. Wnt signaling activation and mammary gland hyperplasia in MMTV-LRP6 transgenic mice: implication for breast cancer tumorigenesis.
Zhang J; Li Y; Liu Q; Lu W; Bu G
Oncogene; 2010 Jan; 29(4):539-49. PubMed ID: 19881541
[TBL] [Abstract][Full Text] [Related]
11. Conditionally reprogrammed normal and transformed mouse mammary epithelial cells display a progenitor-cell-like phenotype.
Saenz FR; Ory V; AlOtaiby M; Rosenfield S; Furlong M; Cavalli LR; Johnson MD; Liu X; Schlegel R; Wellstein A; Riegel AT
PLoS One; 2014; 9(5):e97666. PubMed ID: 24831228
[TBL] [Abstract][Full Text] [Related]
12. Acceleration of mouse mammary tumor virus-induced murine mammary tumorigenesis by a p53 172H transgene: influence of FVB background on tumor latency and identification of novel sites of proviral insertion.
Chatterjee G; Rosner A; Han Y; Zelazny ET; Li B; Cardiff RD; Perkins AS
Am J Pathol; 2002 Dec; 161(6):2241-53. PubMed ID: 12466138
[TBL] [Abstract][Full Text] [Related]
13. Genetic deletion of caspase-2 accelerates MMTV/c-neu-driven mammary carcinogenesis in mice.
Parsons MJ; McCormick L; Janke L; Howard A; Bouchier-Hayes L; Green DR
Cell Death Differ; 2013 Sep; 20(9):1174-82. PubMed ID: 23645210
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of miR-489 derails mammary hierarchy structure and inhibits HER2/neu-induced tumorigenesis.
Patel Y; Soni M; Awgulewitsch A; Kern MJ; Liu S; Shah N; Singh UP; Chen H
Oncogene; 2019 Jan; 38(3):445-453. PubMed ID: 30104710
[TBL] [Abstract][Full Text] [Related]
15. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
[TBL] [Abstract][Full Text] [Related]
16. CdGAP is required for transforming growth factor β- and Neu/ErbB-2-induced breast cancer cell motility and invasion.
He Y; Northey JJ; Primeau M; Machado RD; Trembath R; Siegel PM; Lamarche-Vane N
Oncogene; 2011 Mar; 30(9):1032-45. PubMed ID: 21042277
[TBL] [Abstract][Full Text] [Related]
17. ErbB2/Neu-induced, cyclin D1-dependent transformation is accelerated in p27-haploinsufficient mammary epithelial cells but impaired in p27-null cells.
Muraoka RS; Lenferink AE; Law B; Hamilton E; Brantley DM; Roebuck LR; Arteaga CL
Mol Cell Biol; 2002 Apr; 22(7):2204-19. PubMed ID: 11884607
[TBL] [Abstract][Full Text] [Related]
18. Loss of periostin/OSF-2 in ErbB2/Neu-driven tumors results in androgen receptor-positive molecular apocrine-like tumors with reduced Notch1 activity.
Sriram R; Lo V; Pryce B; Antonova L; Mears AJ; Daneshmand M; McKay B; Conway SJ; Muller WJ; Sabourin LA
Breast Cancer Res; 2015 Jan; 17(1):7. PubMed ID: 25592291
[TBL] [Abstract][Full Text] [Related]
19. Evolution of somatic mutations in mammary tumors in transgenic mice is influenced by the inherited genotype.
Podsypanina K; Li Y; Varmus HE
BMC Med; 2004 Jun; 2():24. PubMed ID: 15198801
[TBL] [Abstract][Full Text] [Related]
20. Cooperative signaling between Wnt1 and integrin-linked kinase induces accelerated breast tumor development.
Oloumi A; Maidan M; Lock FE; Tearle H; McKinney S; Muller WJ; Aparicio SA; Dedhar S
Breast Cancer Res; 2010; 12(3):R38. PubMed ID: 20565980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
